707 Cayman Holdings Limited, a Hong Kong-based apparel seller and supply-chain management provider listed on Nasdaq under JEM, has entered a non-binding Term Sheet to acquire Crucial Innovation Inc., an integrated pharmaceutical botanical therapeutics company. The proposed transaction is subject to due diligence, PCAOB-audited financial statements, an independent fairness opinion where required, definitive agreements and corporate, shareholder, regulatory and Nasdaq approvals. Subject to those conditions, the combination is expected to be supported by US$10.25 million of committed financing led by GeoNova Holdings and its co-investors. CINV is developing a vertically integrated platform covering cultivation, GMP processing, formulation, clinical research and patient access, with medical cannabis as its commercial foundation and additional opportunities in neuroactive botanicals such as Sceletium. It has routes to market in the UK, Germany and Australia and is researching therapies in oncology, pain management and opioid-replacement treatment.